Median Price is the midpoint of the high and low, showing the center of the session's trading range.
Day Median Price Analysis Today
Median Price is the midpoint of the high and low, showing the center of the session's trading range. The current Day Median Price for Evaxion Biotech AS is 4.26. This reading indicates consistent price behavior relative to the prior session.
On May 10 2026 Evaxion Biotech AS was traded for 4.34 at the closing time. The top price for the day was 4.50 and the lowest listed price was 4.01 . Trading activity remained within a narrow range during the period. Price movement on May 10, 2026 remained within defined bounds. The net trading delta against the current closing price is -7.60% .
It provides a single representative price that smooths out intraday extremes. Median Price is commonly used as an input to other technical calculations rather than as a standalone signal.
Related Price-Series Methods for Evaxion Biotech AS
These methods summarize the same price history through smoothing, range, and momentum calculations. Reviewing them alongside Day Median Price helps compare stable sessions with periods of wider price movement in Evaxion Biotech AS.
These related stocks within the Health Care space give benchmarks for judging Evaxion Biotech's results, margins, and growth trend. Profit comparisons show whether Evaxion Biotech earns above or below average returns next to its peers.
Market strength indicators for Evaxion Biotech stock provide a framework for assessing security responsiveness. A rising Accumulation/Distribution line alongside rising price confirms institutional buying interest in Evaxion Biotech.
Assessing Evaxion Biotech's risk indicators is a structured way to evaluate the risk-return trade-off for evaxion biotech stock. The level of risk embedded in Evaxion Biotech's feeds directly into exposure calibration.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Evaxion Biotech Short Properties
Short sentiment tied to Evaxion Biotech AS matters because heavier bearish pressure can change how quickly future price expectations become unstable. A disciplined short-interest review can make timing decisions more informed under rising skepticism.
Common Stock Shares Outstanding
6.41 million
Cash And Short Term Investments
23.23 million
More Resources for Evaxion Biotech Stock Analysis
Understanding Evaxion Biotech AS starts with reviewing its financial statements and long-term patterns. Additional context for Evaxion Biotech AS Stock is provided in the reports below: